These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31509504)

  • 21. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypaphorine Attenuates Lipopolysaccharide-Induced Endothelial Inflammation via Regulation of TLR4 and PPAR-γ Dependent on PI3K/Akt/mTOR Signal Pathway.
    Sun H; Zhu X; Cai W; Qiu L
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
    Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
    Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice.
    Li Y; Xia T; Li R; Tse G; Liu T; Li G
    Med Sci Monit; 2019 Mar; 25():1582-1589. PubMed ID: 30820023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro.
    Freudlsperger C; Moll I; Schumacher U; Thies A
    Anticancer Drugs; 2006 Mar; 17(3):325-32. PubMed ID: 16520661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.
    Xiao J; Chen W; Lu Y; Zhang X; Fu C; Yan Z; Zhang Z; Ye Z
    Inflamm Res; 2015 Aug; 64(8):603-14. PubMed ID: 26072064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice.
    Du J; Niu X; Wang R; Zhao S; Kong L; Zhang Y; Nan Y
    Mol Med Rep; 2016 Mar; 13(3):2159-66. PubMed ID: 26781175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-γ pathway.
    Kole L; Sarkar M; Deb A; Giri B
    Pharmacol Rep; 2016 Feb; 68(1):144-54. PubMed ID: 26721366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway.
    Wu K; Yang Y; Liu D; Qi Y; Zhang C; Zhao J; Zhao S
    Oncotarget; 2016 Jul; 7(28):44572-44582. PubMed ID: 27323819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of peroxisome proliferator-activated receptor γ agonist through activation of Akt and signal transducers and activators of transcription 3 in transient forebrain ischemia.
    Sui X; Yoshioka H; Wakai T; Fukumoto Y; Kinouchi H
    Neuroreport; 2020 Apr; 31(6):484-489. PubMed ID: 32243355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3.
    Németh Á; Mózes MM; Calvier L; Hansmann G; Kökény G
    BMC Nephrol; 2019 Jul; 20(1):245. PubMed ID: 31277592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ.
    Murakami-Nishida S; Matsumura T; Senokuchi T; Ishii N; Kinoshita H; Yamada S; Morita Y; Nishida S; Motoshima H; Kondo T; Komohara Y; Araki E
    Atherosclerosis; 2019 Jul; 286():30-39. PubMed ID: 31096071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
    Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
    Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone, PPARγ agonist, attenuates experimental autoimmune neuritis.
    Ramkalawan H; Wang YZ; Hurbungs A; Yang YF; Tian FF; Zhou WB; Li J; Yang H; Xiao B; Zhang W
    Inflammation; 2012 Aug; 35(4):1338-47. PubMed ID: 22389055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
    Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
    Smith AG; Beaumont KA; Smit DJ; Thurber AE; Cook AL; Boyle GM; Parsons PG; Sturm RA; Muscat GE
    Int J Biochem Cell Biol; 2009 Apr; 41(4):844-52. PubMed ID: 18822385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice.
    Shen D; Li H; Zhou R; Liu MJ; Yu H; Wu DF
    Exp Gerontol; 2018 Feb; 102():101-108. PubMed ID: 29221940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The critical role of ABCG1 and PPARγ/LXRα signaling in TLR4 mediates inflammatory responses and lipid accumulation in vascular smooth muscle cells.
    Cao X; Zhang L; Chen C; Wang Q; Guo L; Ma Q; Deng P; Zhu G; Li B; Pi Y; Long C; Zhang L; Yu Z; Zhou Z; Li J
    Cell Tissue Res; 2017 Apr; 368(1):145-157. PubMed ID: 27807703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.